|
| 37871306 | Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma. | Blood Adv | 2024 |
| 37706336 | A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma. | Haematologica | 2024 |
| 36416736 | Allogeneic natural killer cell therapy. | Blood | 2023 |
| 37910143 | Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. | Cancer Res Commun | 2023 |
| 37556118 | Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer. | Clin Cancer Res | 2023 |
| 37824796 | Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report. | JCO Precis Oncol | 2023 |
| 37493986 | Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303. | Blood Adv | 2023 |
| 37425790 | Engineering Human Pluripotent Stem Cell Lines to Evade Xenogeneic Transplantation Barriers. | bioRxiv | 2023 |
| 37183115 | Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies. | Clin Lymphoma Myeloma Leuk | 2023 |
| 37279078 | T-BET and EOMES sustain mature human NK cell identity and antitumor function. | J Clin Invest | 2023 |
| 37399471 | Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc. | Blood Adv | 2023 |
| 36967480 | Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice. | Aging Cell | 2023 |
| 37477653 | Good manufacturing practice production of CD34<sup>+</sup> progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia. | Cancer Immunol Immunother | 2023 |
| 37130030 | Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction. | Blood | 2023 |
| 37027480 | Computational prediction of MHC anchor locations guides neoantigen identification and prioritization. | Sci Immunol | 2023 |
| 36747791 | Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction. | bioRxiv | 2023 |
| 34797911 | Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy. | Blood | 2022 |
| 35740596 | Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma. | Cancers (Basel) | 2022 |
| 36461582 | Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy. | Int Immunopharmacol | 2022 |
| 35284622 | A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells. | Mol Ther Oncolytics | 2022 |
| 34871371 | Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant. | Blood | 2022 |
| 35196021 | Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia. | Sci Transl Med | 2022 |
| 34780623 | Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma. | Blood | 2022 |
| 33986022 | Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30<sup>+</sup> Malignancies. | Clin Cancer Res | 2021 |
| 35590201 | A Systemic Protein Deviation Score Linked to PD-1<sup>+</sup> CD8<sup>+</sup> T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma. | Med | 2021 |
| 33490978 | Flow cytometry-based <i>ex vivo</i> murine NK cell cytotoxicity assay. | STAR Protoc | 2021 |
| 33832946 | Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma. | Clin Cancer Res | 2021 |
| 34423790 | CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy. | JCI Insight | 2021 |
| 34187852 | Memory-like Differentiation Enhances NK Cell Responses to Melanoma. | Clin Cancer Res | 2021 |
| 34077722 | Reliance on Cox10 and oxidative metabolism for antigen-specific NK cell expansion. | Cell Rep | 2021 |
| 34244297 | A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy. | Cancer Immunol Res | 2021 |
| 32510326 | CD56 regulates human NK cell cytotoxicity through Pyk2. | Elife | 2020 |
| 32102931 | Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. | Sci Transl Med | 2020 |
| 32092137 | KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. | Blood Adv | 2020 |
| 33256911 | Memory-like natural killer cells for cancer immunotherapy. | Semin Hematol | 2020 |
| 32829079 | A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma. | Biol Blood Marrow Transplant | 2020 |
| 32826231 | Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia. | Cancer Discov | 2020 |
| 32614951 | CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas. | Blood | 2020 |
| 32492428 | Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity. | Cell Rep | 2020 |
| 32484854 | Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient. | Blood Adv | 2020 |
| 32197069 | Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development. | Dev Cell | 2020 |
| 31109944 | Mystery Solved: IL-15. | J Immunol | 2019 |
| 31402259 | MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. | Immunity | 2019 |
| 31633216 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). | Eur J Immunol | 2019 |
| 31618044 | Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes. | JCO Clin Cancer Inform | 2019 |
| 28597723 | Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. | Leuk Lymphoma | 2018 |
| 30030269 | Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance). | Blood Adv | 2018 |
| 30026477 | Comment on: Evidence of innate lymphoid cell redundancy in humans. | Nat Immunol | 2018 |
| 30397337 | A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. | Nat Genet | 2018 |
| 29724719 | <i>MIR142</i> Loss-of-Function Mutations Derepress ASH1L to Increase <i>HOXA</i> Gene Expression and Promote Leukemogenesis. | Cancer Res | 2018 |